A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Number of shares, 3 months chart
Year | Volume (Price x Shares) | Change |
---|---|---|
2025 | C$0.75 M | -37.43% |
2024 | C$1.2 M | -44.15% |
2023 | C$2.15 M | -89.19% |
2022 | C$19.92 M | -20.28% |
2021 | C$24.99 M | 31.2% |
2020 | C$19.05 M | 9.95% |
2019 | C$17.32 M | 59.52% |
2018 | C$10.86 M | 1415.4% |
2017 | C$0.71 M | 181.93% |
2016 | C$0.25 M | -79.05% |
2015 | C$1.21 M | -17.49% |
2014 | C$1.47 M | -81.78% |
2013 | C$8.07 M |
Company | FTD volume (3 months) | FTD volume (1 year) | Country |
---|---|---|---|
![]() Sarepta Therapeutics
SRPT | C$11.68 M | C$23.74 M | ๐บ๐ธ USA |
![]() Becton Dickinson BDX | C$45.07 M | C$97.89 M | ๐บ๐ธ USA |
![]() PTC Therapeutics
PTCT | C$1 M | C$31.73 M | ๐บ๐ธ USA |
![]() Avidity Biosciences RNA | C$7.38 M | C$19.54 M | ๐บ๐ธ USA |
![]() Neurocrine Biosciences
NBIX | C$10.26 M | C$35.28 M | ๐บ๐ธ USA |